AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Indinavir crystallization around the loop of Henle: Experimental evidence
Authors: Dieleman, JP Salahuddin, S Hsu, YS Burger, DM Gyssens, IC Sturkenboom, MCJM Stricker, BHC Kok, DJ
Citation: Jp. Dieleman et al., Indinavir crystallization around the loop of Henle: Experimental evidence, J ACQ IMM D, 28(1), 2001, pp. 9-13
A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy
Authors: Burger, DM Hugen, PWH Aarnoutse, RE Dieleman, JP Prins, JM van der Poll, T ten Veen, JH Mulder, JW Meenhorst, PL Blok, WL van der Meer, JTM Reiss, P Lange, JMA
Citation: Dm. Burger et al., A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy, J ACQ IMM D, 26(3), 2001, pp. 218-224
High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices
Authors: Aarnoutse, RE Wissen, CPWGMVV Underberg, WJM Kleinnijenhuis, J Hekster, YA Burger, DM
Citation: Re. Aarnoutse et al., High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices, J CHROMAT B, 764(1-2), 2001, pp. 363-384
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
Authors: Foudraine, NA Jurriaans, S Weverling, GJ Burger, DM Hoetelmans, RMW Roos, MTL Maas, J Miedema, F Reiss, P Portegies, P de Wolf, F Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62
Belowground biomass seasonal variation in two Neotropical savannahs (Brazilian Cerrados) with different fire histories
Authors: Delitti, WBC Pausas, JG Burger, DM
Citation: Wbc. Delitti et al., Belowground biomass seasonal variation in two Neotropical savannahs (Brazilian Cerrados) with different fire histories, ANN FOR SCI, 58(7), 2001, pp. 713-721
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
Authors: Koks, CHW Crommentuyn, KML Hoetelmans, RMW Burger, DM Koopmans, PP Mathot, RAA Mulder, JW Meenhorst, PL Beijnen, JH
Citation: Chw. Koks et al., The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals, BR J CL PH, 51(6), 2001, pp. 631-635
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients
Authors: Baede-van Dijk, PA Hugen, PWH Verweij-van Wissen, CPWGM Koopmans, PP Burger, DM Hekster, YA
Citation: Pa. Baede-van Dijk et al., Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients, AIDS, 15(8), 2001, pp. 991-998
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children
Authors: Burger, DM van Rossum, AMC Hugen, PWH Suur, MH Hartwig, NG Geelen, SPM Scherpbier, HJ Hoetelmans, RMW Vulto, AG de Groot, R
Citation: Dm. Burger et al., Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children, ANTIM AG CH, 45(3), 2001, pp. 701-705
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study
Authors: Nieuwkerk, PT Sprangers, MAG Burger, DM Hoetelmans, RMW Hugen, PWH Danner, SA van der Ende, ME Schneider, MME Schrey, G Meenhorst, PL Sprenger, HG Kauffmann, RH Jambroes, M Chesney, MA de Wolf, F Lange, JMA
Citation: Pt. Nieuwkerk et al., Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, ARCH IN MED, 161(16), 2001, pp. 1962-1968
Dose-finding study of a once-daily indinavir/ritonavir regimen
Authors: Hugen, PWH Burger, DM ter Hofstede, HJM Koopmans, PP Stek, M Hekster, YA Reiss, P Lange, JMA
Citation: Pwh. Hugen et al., Dose-finding study of a once-daily indinavir/ritonavir regimen, J ACQ IMM D, 25(3), 2000, pp. 236-245
Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptaseinhibitor, in human plasma by reversed-phase high-performance liquid chromatography
Authors: Hollanders, RMF Kolmer, EWJV Burger, DM Wuis, EW Koopmans, PP Hekster, YA
Citation: Rmf. Hollanders et al., Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptaseinhibitor, in human plasma by reversed-phase high-performance liquid chromatography, J CHROMAT B, 744(1), 2000, pp. 65-71
Carbon and mineral nutrient pools in a gallery forest at Mogi Guacu River,Southeast Brazil
Authors: Delitti, WBC Burger, DM
Citation: Wbc. Delitti et Dm. Burger, Carbon and mineral nutrient pools in a gallery forest at Mogi Guacu River,Southeast Brazil, ANN FOR SCI, 57(1), 2000, pp. 39-47
Development of an indinavir oral liquid for children
Authors: Hugen, PWH Burger, DM ter Hofstede, HJM Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Development of an indinavir oral liquid for children, AM J HEAL S, 57(14), 2000, pp. 1332-1339
Carbamazepine-indinavir interaction causes antiretroviral therapy failure
Authors: Hugen, PWH Burger, DM Brinkman, K ter Hofstede, HJM Schuurman, R Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Carbamazepine-indinavir interaction causes antiretroviral therapy failure, ANN PHARMAC, 34(4), 2000, pp. 465-470
Potential risk of valproic acid therapy in patients who are HIV-positive -Reply
Authors: Hugen, PWH Burger, DM
Citation: Pwh. Hugen et Dm. Burger, Potential risk of valproic acid therapy in patients who are HIV-positive -Reply, ANN PHARMAC, 34(11), 2000, pp. 1349-1349
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
Authors: van Praag, RME Weverling, GJ Portegies, P Jurriaans, S Zhou, XJ Turner-Foisy, ML Sommadossi, JP Burger, DM Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir, AIDS, 14(9), 2000, pp. 1187-1194
No drug-drug interaction between nelfinavir or indinavir and mefloquine inHIV-1-infected patients
Authors: Schippers, EF Hugen, PWH den Hartigh, J Burger, DM Hoetelmans, RMW Visser, LG Kroon, FP
Citation: Ef. Schippers et al., No drug-drug interaction between nelfinavir or indinavir and mefloquine inHIV-1-infected patients, AIDS, 14(17), 2000, pp. 2794-2795
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study
Authors: Burger, DM Hugen, PWH van der Ende, ME van Wijngaarden, P Aarnoutse, RE Reiss, P Lange, JMA
Citation: Dm. Burger et al., Once-daily indinavir plus ritonavir: preliminary results of the PIPO study, AIDS, 14(16), 2000, pp. 2621-2623
Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection
Authors: van Rossum, AMC de Groot, R Hartwig, NG Weemaes, CMR Head, S Burger, DM
Citation: Amc. Van Rossum et al., Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection, AIDS, 14(14), 2000, pp. 2209-2210
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir
Authors: Hugen, PWH Burger, DM de Graaff, M ter Hofstede, HJM Hoetelmans, RMW Brinkman, K Meenhorst, PL Mulder, JW Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir, THER DRUG M, 22(4), 2000, pp. 437-445
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands
Authors: van Rossum, AMC Niesters, HGM Geelen, SPM Scherpbier, HJ Hartwig, NG Weemaes, CMR Veerman, AJP Suur, MH de Graeff-Meeder, ER Slicker, WAT Hop, WCJ Osterhaus, ADME Burger, DM de Groot, R
Citation: Amc. Van Rossum et al., Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands, J PEDIAT, 136(6), 2000, pp. 780-788
Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography
Authors: Hugen, PWH Verweij-van Wissen, CPWGM Burger, DM Wuis, EW Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography, J CHROMAT B, 727(1-2), 1999, pp. 139-149
Stability of dithranol in creams
Authors: Wuis, EW Burger, DM Beelen, M Hekster, YA
Citation: Ew. Wuis et al., Stability of dithranol in creams, PHARM WORLD, 21(6), 1999, pp. 275-277
Long-term stability of morphine and bupivacaine mixture for spinal use
Authors: Essink-Tjebbes, CM Burger, DM Beelen, M Wuis, EW Hekster, YA
Citation: Cm. Essink-tjebbes et al., Long-term stability of morphine and bupivacaine mixture for spinal use, PHARM WORLD, 21(3), 1999, pp. 144-146
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)
Authors: Stuart, JWTC Schuurman, R Burger, DM Koopmans, PP Sprengers, HG Juttmann, JR Richter, C Meenhorst, PL Hoetelmans, RMW Kroon, FP Bravenboer, B Hamann, D Boucher, CAB Borleffs, JCC
Citation: Jwtc. Stuart et al., Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study), AIDS, 13(7), 1999, pp. F53-F58
Risultati: 1-25 | 26-30